Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of New FluMist Strain in Adults
NCT03158038Phase 4Completed
- Sponsor
- MedImmune
- Start
- May 2017
- Primary completion
- Dec 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of live attenuated influenza vaccine in influenza (2 arms), sponsored by MedImmune. Primary endpoint: Percentage of Participants With Fever Greater Than or Equal to 101 Degrees Fahrenheit. Started May 2017; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03158038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03158038.